文献速递肝胆胰外科

肝移植与部分肝切除术治疗无血管侵犯的T2多灶性肝细胞癌:倾向性评分匹配生存分析

Liver Transplantation vs Partial Hepatectomy for Stage T2 Multifocal Hepatocellular Carcinoma <3 cm Without Vascular Invasion: A Propensity Score-Matched Survival Analysis.
PubMed 文献 · J Am Coll Surg · 2023-04-27

该研究基于2020年美国国家癌症数据库,纳入符合米兰标准、无血管侵犯、最大肿瘤直径<3 cm的多灶性T2期肝细胞癌患者,采用倾向性评分匹配和Cox回归比较肝移植与部分肝切除术的总生存。匹配后肝移植相对部分肝切除术的风险比为0.39(95%CI 0.30-0.50),landmark分析显示相似幅度的生存获益。

要点

  • 在符合米兰标准的多灶性T2期肝细胞癌患者中,肝移植较部分肝切除术显示生存获益。
  • 倾向性评分匹配后肝移植相对部分肝切除术的风险比为0.39(95%CI 0.30-0.50)。
  • landmark分析校正肝移植等待间隔后,生存获益幅度相似。

核心结论

  • 倾向性评分匹配分析显示,在符合米兰标准的多灶性肝细胞癌患者中,肝移植相对部分肝切除术具有生存获益。

研究设计与样本

  • 基于2020年美国国家癌症数据库的倾向性评分匹配观察性研究,纳入接受肝移植或部分肝切除术的多灶性T2期肝细胞癌患者。
  • 共识别21248例T2期肝细胞癌患者,其中6744例为最大肿瘤直径<3 cm且无大血管侵犯的多灶性肿瘤,1267例接受肝移植、181例接受部分肝切除术。
  • 采用倾向性评分匹配和Cox回归分析评估总生存,匹配因素包括年龄、性别、治疗机构类型、治疗年份、凝血酶原时间、甲胎蛋白、合并症负担、肝纤维化严重程度及治疗前肌酐和胆红素水平。

主要发现

  • 倾向性评分匹配的Cox回归分析显示,肝移植相对部分肝切除术的风险比为0.39(95%CI 0.30-0.50)。
  • 考虑肝移植等待间隔较长的landmark分析显示生存获益幅度相似。

关键数值与推荐

  • 匹配后肝移植相对部分肝切除术的风险比为0.39(95%CI 0.30-0.50)。

临床怎么用

  • 对于符合米兰标准、无血管侵犯的多灶性T2期肝细胞癌患者,肝移植可能较部分肝切除术提供生存优势。
  • 临床决策时可结合指南对肝移植的倾向性及患者具体情况综合评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multifocal hepatocellular carcinoma (HCC) differs biologically and immunologically from single-nodule HCC. Asian and European guidelines consider liver transplantation (LT) and partial hepatectomy (PH) as effective for T2 multifocal HCC, with preference toward LT, but few US studies compare these treatments directly. This propensity score-based observational study uses an established national cancer outcomes registry to compare overall survival in patients undergoing PH and LT for multifocal HCC. STUDY DESIGN: Data from the 2020 National Cancer Database were obtained on patients who underwent LT or PH for multifocal stage 2 HCC within Milan criteria and without vascular invasion. Propensity score matching and Cox regression analysis was applied to evaluate overall survival in an observational cohort balanced by age, sex, treatment facility type, treatment year, prothrombin time, α-fetoprotein, comorbidity burden, liver fibrosis severity, and pretreatment creatinine and bilirubin levels. RESULTS: Of 21,248 T2 HCC patients identified, 6,744 had multifocal tumors with largest tumor diameter <3 cm without major vascular invasion, with 1,267 and 181 having undergone LT and PH, respectively. Propensity score-matched Cox regression analysis associated LT with a hazard ratio of 0.39 (95% CI 0.30 to 0.50) relative to PH. Landmark analyses to account for a longer interval to LT demonstrated survival benefits of similar magnitude. CONCLUSIONS: Although early-stage HCC can be effectively treated with either LT or PH, propensity score-matched analysis comparatively shows a survival benefit for LT in patients with multifocal HCC who are within the Milan criteria.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Wong LL, Landsittel DP, Kwee SA, et al. Liver Transplantation vs Partial Hepatectomy for Stage T2 Multifocal Hepatocellular Carcinoma <3 cm Without Vascular Invasion: A Propensity Score-Matched Survival Analysis. J Am Coll Surg. 2023. PMID: 37102575. doi:10.1097/XCS.0000000000000725

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。